Welcome to the new beta version of legal500.com Visit the legacy site

North America - United States • Intellectual property

Goodwin

More informationMore information

Goodwin acts on behalf of clients in various industries, such as technology, life sciences, and financial services, in relation to developing and implementing patent procurement, management, and exploitation policies. In addition, the department also covers patent enforcement and IP litigation, and it is also active in advising on licensing and technology transactions. Catherine McCarty co-leads the team in Boston and specializes in matters concerning the pharma sector, while James Riley co-leads the department from the firm’s Silicon Valley office, representing emerging growth technology companies and venture capital firms. In Boston, Stephen Charkoudian covers technology, data and intellectual property transactions, Kingsley Taft is a key contact for clients in the biotechnology sector, and Bethany Withers chiefly advises tech companies on data, publicity rights, and intellectual property issues. Noelle Dubiansky in Washington DC frequently assists biotechnology, pharmaceutical, medical device, and various other life science enterprises with M&A transactions, strategic partnerships, and tech acquisitions.

Legal 500 Editorial commentary

Key clients

  • Alert Innovation
  • OncoC4
  • WHP Global
  • Jnana Therapeutics
  • Adare Pharma Solutions
  • Kelun-Biotech
  • Wave Life Sciences
  • Entrada Therapeutics
  • Teva
  • Seagen
  • Orionis Biosciences
  • Nanobiotix
  • Bit.bio
  • Bev
  • Pioneering Medicines
  • Synaffix B.V.
  • Clockworks Analytics

Work highlights

  • Advised Alert Innovation on its $650m definitive agreement to be acquired by Walmart.
  • Advised OncoC4 in its agreement with BioNTech SE pursuant to which BioNTech receives an exclusive worldwide license to co-develop and commercialize OncoC4’s anti-CTLA-4 monoclonal antibody candidate.
  • Advised Sichuan Kelun-Biotech Biopharmaceutical in its exclusive license and collaboration agreement with Merck to develop seven investigational preclinical antibody-drug conjugates for the treatment of cancer.

Practice head

The lawyer(s) leading their teams.

Catherine McCarty, James Riley

Other key lawyers

Stephen Charkoudian, Kingsley Taft, Noelle Dubiansky, Bethany Withers, Sarah Solomon